Conrad v. Boiron, Inc., No. 16-3656 (7th Cir. 2017)Annotate this Case
Boiron makes homeopathic products, including an over‐the‐counter remedy called Oscillo that retails for between $12 and $20. Oscillo is made by mixing one percent Anas Barbariae Hepatis et Cordis Extractum (duck hearts and livers) with 99 percent water, repeating the dilution process 200 times, and then selling the result in pill form. The repeated dilutions render the finished product nothing more than a placebo. Boiron’s claim that Oscillo has a therapeutic effect on flu symptoms is “highly doubtful.” Conrad filed a class action against Boiron for deceptive marketing. About a year later Boiron offered Conrad $5,025, more than he could hope to win at trial. Conrad did not accept the money because it would moot his claim. The district court refused to certify Conrad’s proposed class and found his individual claim moot. The Seventh Circuit remanded; an unaccepted offer cannot moot a case. There are other measures available to address the problem (if it exists here) of “unreasonably and vexatiously” persisting in litigation, such as 28 U.S.C. 1927, but the district court did not decide whether they should be used.